文献速递甲状腺核医学

根据ATA 2015、EU-TIRADS和ACR-TIRADS需行细针穿刺细胞学的甲状腺结节中高功能结节的患病率

Prevalence of hyperfunctioning thyroid nodules among those in need of fine needle aspiration cytology according to ATA 2015, EU-TIRADS, and ACR-TIRADS.
PubMed 文献 · Eur J Nucl Med Mol Imaging · 2020-03-09

该回顾性研究纳入2013年9月至2018年2月在本院因甲状腺结节行超声和闪烁显像的566例甲状腺功能正常患者,按ATA 2015、EU-TIRADS和ACR-TIRADS对1029个≥10 mm结节分类并与99mTc-高锝酸盐闪烁显像功能状态相关。需行细针穿刺的结节中高功能结节患病率在≥10 mm时为6.4%、6.9%、6.5%,≥15 mm时为7.2%、7.6%、7.5%,无超声特征与高功能相关。作者认为甲状腺闪烁显像可降低甲状腺功能正常患者的细针穿刺频率并可能减少诊断性半甲状腺切除术频率。

要点

  • 甲状腺功能正常患者中,按超声分类需行细针穿刺的结节约6.4%–6.9%为高功能结节。
  • 无超声特征与结节高功能状态相关。
  • 作者认为闪烁显像可降低细针穿刺频率并可能减少诊断性半甲状腺切除术。

核心结论

  • 在甲状腺功能正常患者中,甲状腺闪烁显像可显示超声无法预测的高功能结节,按超声分类需行细针穿刺的结节中该比例高达6.9%。
  • 鉴于高功能结节已知的低恶性风险,甲状腺闪烁显像可降低甲状腺功能正常患者的细针穿刺频率并可能降低诊断性半甲状腺切除术频率。

研究设计与样本

  • 回顾性研究纳入2013年9月至2018年2月在本院行甲状腺超声和闪烁显像的566例甲状腺功能正常(TSH 0.55–4.20 μU/ml)患者。
  • 所有>10 mm结节按ATA、EU-TIRADS和ACR-TIRADS分类,并与99mTc-高锝酸盐闪烁显像评估的功能状态相关。

主要发现

  • 超声检出1029个≥10 mm甲状腺结节,其中545个≥15 mm。
  • 按ATA 2015、EU-TIRADS和ACR-TIRADS需行细针穿刺的结节中,高功能结节患病率在≥10 mm结节分别为6.4%、6.9%、6.5%,在≥15 mm结节分别为7.2%、7.6%、7.5%。
  • 无超声特征与结节高功能相关。

临床怎么用

  • 作者认为,甲状腺闪烁显像可降低甲状腺功能正常患者的细针穿刺频率并可能降低诊断性半甲状腺切除术频率。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Given the large number of patients with thyroid nodules, improvement of the specificity of current ultrasound-based thyroid nodule classification systems (ATA, EU-TIRADS, and ACR-TIRADS) is warranted to reduce the number of diagnostic thyroidectomies. Thyroid scintigraphy has been shown to demonstrate hyperfunctional nodules, associated with a low malignancy risk, in euthyroid patients. However, it is not known if thyroid scintigraphy could improve specificity of current classification systems. The aim of this study, therefore, was to determine the frequency of hyperfunctional nodules among those nodules in need of fine needle aspiration cytology (FNA) according to current classification systems and to test if nodule functional status is associated with sonographic features. METHODS: Five hundred sixty-six euthyroid patients (TSH 0.55-4.20 μU/ml) presenting for thyroid nodule workup including thyroid sonography and scintigraphy at our department between 09/2013 and 02/2018 were included in this retrospective study. All nodules > 10 mm were classified according to ATA, EU-TIRADS, and ACR-TIRADS and correlated to their functional status as assessed by 99mTc-pertechnetate scintigraphy. RESULTS: Ultrasound detected 1029 thyroid nodules ≥ 10 mm, including 545 nodules ≥ 15 mm. Prevalence of hyperfunctional nodules among those with recommendation for FNA according to ATA 2015, EU-TIRADS, and ACR-TIRADS was 6.4%, 6.9%, and 6.5% for nodules ≥ 10 mm and 7.2%, 7.6%, and 7.5% only considering nodules ≥ 15 mm. No sonographic feature was correlated to hyperfunctionality of nodules. CONCLUSION: In euthyroid patients, thyroid scintigraphy demonstrates hyperfunctionality, which cannot be predicted by ultrasound, in up to 6.9% of nodules in need of FNA according to ultrasound-based classifications. Given the known low risk of malignancy in hyperfunctional nodules, thyroid scintigraphy can lower the frequency of fine needle aspirations and-potentially-the frequency of diagnostic hemithyroidectomies in euthyroid patients.

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. Noto B, Eveslage M, Pixberg M, et al. Prevalence of hyperfunctioning thyroid nodules among those in need of fine needle aspiration cytology according to ATA 2015, EU-TIRADS, and ACR-TIRADS. Eur J Nucl Med Mol Imaging. 2020. PMID: 32152666. doi:10.1007/s00259-020-04740-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。